Survival outcomes of myeloid leukemia associated with Down syndrome and de novo acute myeloid leukemia in children: Experience from a single tertiary center in Thailand-Reference-Cited by-同舟云学术

Survival outcomes of myeloid leukemia associated with Down syndrome and de novo acute myeloid leukemia in children: Experience from a single tertiary center in Thailand

Published:2023-11-27 Issue: Volume: Page:1-13
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Songthawee Natsaruth¹,Sripornsawan Pornpun¹^ORCID,Chavananon Shevachut¹^ORCID,Kittivisuit Sirinthip²^ORCID,McNeil Edward B.³^ORCID,Chotsampancharoen Thirachit¹^ORCID

Affiliation:

1. Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand

2. Division of Rheumatology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand

3. Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2023.2286970

Reference40 articles.

1. Risks of leukaemia and solid tumours in individuals with Down's syndrome

2. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome

3. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

4. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia

5. Transient abnormal myelopoiesis in Down syndrome: Experience of long term follow up from a single tertiary center in Thailand